N. Iradyan

Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review)

F. Arsenyan, B. T. Garibdzhanyan, G. M. Stepanyan, 2010, Pharmaceutical Chemistry Journal.

Development of Targeted EGFR Degradation for Cancer Treatment

V. Sakanyan, M. Iradyan, N. Iradyan, 2022, Reports of NAS RA.

Imidazole Derivatives. XXIX. Synthesis and Biological Activity of Thiosemicarbazides and Hydrazonohydrazides of 4-Nitroimidazole-5-thioacetic Acids

F. Arsenyan, B. T. Garibdzhanyan, G. M. Stepanyan, 2003, Pharmaceutical Chemistry Journal.

Imidazole derivatives. XXVI. Synthesis of imidazole-2-carboxaldehyde derivatives and their antitumorigenic, mutagenic and antimutagenic action

F. Arsenyan, B. T. Garibdzhanyan, G. M. Stepanyan, 1991, Pharmaceutical Chemistry Journal.

Imidazole derivatives and their antitumor activity (review)

F. Arsenyan, G. M. Stepanyan, M. Iradyan, 2009, Pharmaceutical Chemistry Journal.

Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death

G. Bollot, V. Sakanyan, P. Hulin, 2019, Cancers.

Imidazole derivatives XVIII. Synthesis and antitumor activity of some bis[2-chloroethyl]amino imidazole derivatives

F. Arsenyan, B. T. Garibdzhanyan, G. M. Stepanyan, 1984, Pharmaceutical Chemistry Journal.

Imidazole Derivatives. XXVIII. Synthesis and Antitumor Activity of 4(5)-[4-(3,3-Dimethyl-1-triazeno)-3-nitrophenyl]imidazole and Related Compounds

F. Arsenyan, B. T. Garibdzhanyan, G. M. Stepanyan, 2001, Pharmaceutical Chemistry Journal.